Oxidation of aromatic lithium thiolates into sulfinate salts: An attractive entry to aryl sulfones labeled with carbon-11

Journal of Organic Chemistry

Volumn 71, Issue 1, 2006, Pages 210-214

  Martin, Claudie ^a   Sandrinelli, Franck ^a   Perrio, Cécile ^a,b   Perrio, Stéphane ^a   Lasne, Marie Claire ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBONS; CARBON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PURIFICATION;

LABELING METHOD; OXAZIRIDINE; RADIOCHEMICAL YIELDS;

LITHIUM COMPOUNDS;

CARBON 11; IODIDE; LITHIUM DERIVATIVE; LITHIUM SULFINATE; LITHIUM THIOLATE; OXAZIRIDINE DERIVATIVE; RADIOISOTOPE; SULFONE C 11; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; OXIDATION; PURIFICATION; RADIOCHEMISTRY; STRUCTURE ANALYSIS; TEMPERATURE DEPENDENCE;

CARBON RADIOISOTOPES; HYDROCARBONS, IODINATED; LITHIUM; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; SALTS; SULFHYDRYL COMPOUNDS; SULFONES; SULFUR;

EID: 31144467338     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo051942v     Document Type: Article

References (67)

1. (a) Fowler, J. S.; Wolf, A. P. In Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart; Phelps, M., Ed.; Raven Press: New York, 1986; Chapter 9, pp 391-450.
2. (b) Elsinga, P. H. Methods 2002, 27, 208-217.
3. (c) Ferrieri, R. A.; Antoni, G.; Khilberg, T.; Långström, B. In Handbook of Radiopharmaceuticals. Radiochemistry and Applications; Welch, M. J., Redvanly, C. S., Eds.; Wiley: Chichester, 2003; pp 229-282.
4. (a) Kalir, R.; Kalir, H. H. Biological Activity of Sulfoxides and Sulfones. In The Chemistry of Sulphur-containing Functional Group; Patai, S., Rappoport, Z., Eds.; J. Wiley and Sons: Chichester, 1993; Chapter 16, pp 957-973.
5. (b) Lamberth, C. J. Sulfur Chem. 2004, 25, 39-62.
6. (c) Smith, P. H.; Chamberlain, K.; Sugars, J. M.; Bromilow, R. H. Pestic. Sci. 1995, 45, 357-361.
7. (d) Tsuji, K.; Nakamura, K.; Ogino, T.; Konishi, N.; Tojo, T.; Ochi, T.; Seki, N.; Matsuo, M. Chem. Pharm. Bull. 1998, 46, 279-286.
8. (e) Jones, P. B.; Parrish, N. M.; Houston, T. A.; Stapon, A.; Bansal, N. P.; Dick, J. D.; Townsend, C. A. J. Med. Chem. 2000, 43, 3304-3314.
9. (f) Garg, R.; Kurup, A.; Mekapati, S. B.; Mansch, C. Chem. Rev. 2003, 103, 703-731.
10. (g) Pinto, D. J. P.; Orwat, M. J.; Wang, S.; Fevig, J. M.; Quan, M. L.; Amparo, E.; Cacciola, J.; Rossi, K. A.; Alexander, R. S.; Smallwood, A. M.; Luettgen, J. M.; Liang, L.; Aungst, B. J.; Wright, M. R.; Knabb, R. M.; Wong, P. C.; Wexler, R. R.; Lam, P. Y. S. J. Med. Chem. 2001, 44, 566-578.
11. (h) Hudson, S. J.; Bishop, M. J.; Speake, J. D.; Navas, F.; Garrison, D. T.; Bigham, E. C.; Saussy, D. L., Jr.; Liacos, J. A.; Irving, P. E.; Gobel, M. J.; Sherman, B. W. J. Med. Chem. 2002, 45, 2229-2239.
12. (i) Salamon, E.; Mannhold, R.; Weber, H.; Lemoine, H.; Frank, W. J. Med. Chem. 2002, 45, 1086-1097.
13. (j) Fletcher, S. R.; Burkamp, F.; Blurton, P.; Cheng, S. K. F.; Clarkson, R.; O'Connor, D.; Spinks, D.; Tudge, M.; van Niel, M. B.; Patel, S.; Chapman, K.; Marwood, R.; Shepheard, S.; Bentley, G.; Cook, G. P.; Bristow, L. J.; Castro, J. L.; Hutson, P. H.; MacLeod, A. M. J. Med. Chem. 2002, 45, 492-503.
14. (k) Wada, C. K.; Holms, J. H.; Curtin, M. L.; Dai, Y.; Florjancic, A. S.; Garland, R. B.; Guo, Y.; Heyman, H. R.; Stacey, J. R.; Steinman, D. H.; Albert, D. H.; Bouska, J. J.; Elmore, I. N.; Goodfellow, C. L.; Marcotte, P. A.; Tapang, P.; Morgan, D. W.; Michaelides, M. R.; Davidsen, S. K. J. Med. Chem. 2002, 45, 219-232.
15. (l) Campos, K. R.; Journet, M.; Lee, S.; Grabowski, E. J. J.; Tillyer, R. D. J. Org. Chem. 2005, 70, 268-274.
16. (m) Patel, M. V.; Bell, R.; Majest, S.; Henry, R.; Kolasa, T. J. Org. Chem. 2004, 69, 7058-7065.
17. (n) Thérien, M.; Gauthier, J. Y.; Leblanc, Y.; Léger, S.; Perrier, H.; Prasit, P.; Wang, Z. Synthesis 2001, 1778-1779.
18. (o) Giles, M. E.; Thomson, C.; Eyley, S. C.; Cole, A. J.; Goodwin, C. J.; Hurved, P. A.; Morlin, A. J. G.; Tornos, J.; Atkinson, S.; Just, C.; Dean, J. C.; Singleton, J. T.; Longton, A. J.; Woodland, A. J.; Teasdale, A.; Gregertsen, B.; Else, H.; Athwal, M. S.; Tatterton, S.; Knott, J. M.; Knott, J. M.; Thompson, N.; Smith, S. J. Org. Process Res. Dev. 2004, 8, 628-642.
19. (p) Zhang, Y.-M.; Cockerill, S.; Guntrip, S. B.; Rusnak, D.; Smith, K.; Vanderwall, D.; Wood, E.; Lackey, K. Bioorg. Med. Chem. Lett. 2004, 14, 111-114.
20. (q) Masaki, H.; Mizuno, Y.; Tatui, A.; Murakami, A.; Koide, Y.; Satoh, S.; Takahashi, A. Biorg. Med. Chem. Lett. 2003, 13, 4085-4088.
21. (r) Chang, S.-J.; Fernando, D.; Fickes, M.; Gupta, A. K.; Hill, D. R.; McDermott, T.; Parekh, S.; Tian, Z.; Wittenberger, S. J. Org. Process Res. Dev. 2002, 6, 329-335.
22. (s) Lee, K. W.; Hwang, S. Y.; Kim, C. R.; Nam, D. H.; Chang, J. H.; Choi, S. C.; Choi, B. S.; Choi, H.-W.; Lee, K. K.; So, B.; Cho, S. W.; Shin, H. Org. Process Res. Dev. 2003, 7, 329-335.
23. See also references cited in the following: (t) Baskin, J. M.; Wang, Z. Org. Lett. 2002, 4, 4423-4425.
24. (u) Beaulieu, C.; Guay, D.; Wang, Z.; Evans, D. A. Tetrahedron Lett. 2004, 45, 3233-3236.
25. (v) Cacchi, S.; Fabrizi, G.; Goggiamani, A.; Parisi, L. M.; Bernini, R. J. Org. Chem. 2004, 69, 5608-5614.
26. (w) Zhu, W.; Ma, D. J. Org. Chem. 2005, 70, 2696-2700.
27. Van Nispen, J. W.; Janssen, W. P. A.; Melgers, P. A. T. A.; Jansenn, P. S. L.; Jansen, J. F. G. A.; Vaalburg, W. Int. J. Pept. Protein Res. 1990, 36, 167-172.
28. Neu, H.; Hartvig, P.; Torstenson, R.; Fasth, K. J.; Sonesson, C.; Waters, N.; Carlsson, A.; Tedroff, J.; Langstrom, B. Nucl. Med. Biol. 1997, 24, 507-511.
29. (a) Eng, W.-S.; Hamill, T. G.; Francis, B. E.; Fioravanti, C.; Gibson, R. E.; Burns, H. D.; Ravert, H. T.; Mathews, W. B.; Dannals, R. F. J. Labelled Compd. Radiopharm. 1999, 42 (Suppl. 1), S204-S206.
30. (b) Burns, H. D.; Hamill, T. G.; Gibson, R. E. PCT Int. Appl. WO 78363, 2000.
31. (c) Burns, H. D.; Eng, W.-S.; Gibson, R. E. PCT Int. Appl. WO 00654, 1999.
32. Majo, V. J.; Prabhakaran, J.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Kumar, S. D. Bioorg. Med. Chem. Lett. 2005, 15, 4268-4271. This paper describes also the labeling of the COX-2 inhibitors Etoricoxib and Rofecoxib.
33. 18F, see the following: (a) Isakson, P. C.; Seibert, K.; Talley, J. J. PCT Int. Appl. WO 14679, 1997.
34. (b) Wüst, F. R.; Höhne, A.; Metz, P. Org. Biomol. Chem. 2005, 3, 503-507.
35. (c) de Vries, E. F. J.; van Waarde, A.; Buursma, A. R.; Vaalburg, W. J. Nucl. Med. 2003, 44, 1700-1706.
36. (d) McCarthy, T. J.; Sheriff, A. U.; Graneto, M. J.; Talley, J. J.; Welch, M. J. J. Nucl. Med. 2002, 43, 117-124.
37. (e) Toyokuni, T.; Satyamurthy, N.; Herschman, H. R.; Phelps, M. E.; Barrio, J. R. PCT Int. Appl. WO 89013, 2003.
38. Crouzel, C.; Långström, B.; Pike, V. W.; Coenen, H. H. Appl. Radiat. Isot. 1987, 38, 601-603.
39. For Information about syntheses of sulfones, see the following: (a) Ward, R. S.; Diaper, R. L. Sulfur Rep. 2001, 22, 251-275.
40. (b) Simpkins, N. S. In Sulphones in Organic Synthesis; Baldwin, J. E., Magnus, P. D., Eds.; Pergamon Press: Oxford, 1993; Vol. 10.
41. Choudhry, S. C.; Serico, L.; Cupano, J. J. Org. Chem. 1989, 54, 3755-3757.
42. 2 or the deprotection of appropriate sulfones. See, for example, the following: (a) The Chemistry of Sulfinic Acids and their Derivatives-The Chemistry of Functional Groups; Patai, S., Ed.; John Wiley & Sons: Chichester, 1990.
43. (b) Pandya, R.; Murashima, T.; Tedeschi, L.; Barrett, A. G. M. J. Org. Chem. 2003, 68, 8274-8276.
44. (c) Baskin, J. M.; Wang, Z. Tetrahedron Lett. 2002, 43, 8479-8483.
45. (d) Katritzky, A. R.; Rodriguez-Garcia, V.; Nair, S. K. J. Org. Chem. 2004, 69, 1849-1852.
46. (e) Chan, W. Y.; Berthelette, C. Tetrahedron Lett. 2002, 43, 4537-4540.
47. (f) De Vleeschauwer, M.; Gauthier, J. Y. Synlett 1997, 375-377.
48. (g) Baskin, J. M.; Wang, Z. Tetrahedron Lett. 2002, 43, 8479-8483.
49. (h) Pinnick, H. W.; Reynolds, M. A. J. Org. Chem. 1979, 44, 160-161.
50. (a) Sandrinelli, F.; Perrio, S.; Beslin, P. J. Org. Chem. 1997, 62, 8626-8627.
51. (b) Sandrinelli, F.; Perrio, S.; Beslin, P. Org. Lett. 1999, 1, 1177-1180.
52. (c) Sandrinelli, F.; Perrio, S.; Averbuch-Pouchot, M.-T. Org. Lett. 2002, 4, 3619-3622.
53. Sandrinelli, F.; Fontaine, G.; Perrio, S.; Beslin, P. J. Org. Chem. 2004, 69, 6916-6919.
54. Davis, F. A.; Jenkins, R., Jr.; Yocklovich, S. G. Tetrahedron Lett. 1978, 19, 5171-5174.
55. Sulfinates are ambident nucleophiles. With soft electrophiles such as alkyl halides the alkylation occurs predominantly at sulfur to give sulfones: (a) Wu, J.-P.; Emeigh, J.; Su, X.-P. Org. Lett. 2005, 7, 1223-1225.
56. (b) Srivastava, P. K.; Field, L. Phosphorus Sulfur Relat. Elem. 1985, 25, 161-165.
57. (c) Hu, Y.; Chen, Z.-C.; Le, Z.-G.; Zheng, Q.-G. J. Chem. Res. 2004, 267-269.
58. (a) Crandall, J. K.; Pradat, C. J. Org. Chem, 1985, 50, 1327-1329.
59. (b) Deguin, B.; Roulet, J.-M.; Vogel, P. Tetrahedron Lett. 1997, 38, 6197-6200.
60. (a) Kawamura, K.; Eisinga, P. H.; Kobayashi, T.; Ishii, S.-I.; Wang, W.-F.; Matsuno, K.; Vaalburg, W.; Ishiwata, K. Nucl. Med. Biol. 2003, 30, 273-284.
61. (b) Siegers, G.; Sambre, J.; Goethals, P.; Vandecasteele, C.; Van Haver, D. Appl. Radiat. Isot. 1986, 37, 279-292.
62. (a) Guillouet, S.; Barre, L.; Gourand, F.; Lasne, M.-C.; Rault, S. J. Labelled Compd. Radiopharm. 1996, 38, 367-371.
63. (b) Fasth, K.-J.; Hoernfeldt, K.; Långström, B. Acta Chem. Scand. 1995, 49, 301-304.
64. (c) Musachio, J. L.; Mathews, W. B.; Ravet, H. T.; Carroll, F. I.; Dannals, R. F. J. Labelled Compd. Radiopharm. 1994, 34, 49-57.
65. (d) Fasth, K. J.; Långstrom, B. Acta Chem. Scand. 1990, 44, 720-725.
66. (e) Dannals, R. F.; Långstrom, B.; Ravert, H. T.; Wilson, A. A.; Wagner, H. N., Jr. Appl. Radiat. Isot. 1988, 39, 291-295.
67. The weight of the sulfinate salt was slightly superior because of remaining water.